- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03995199
A Comparison of Speech Outcome in Pediatric Cleft Patients, After Modified Furlow-Sommerlad Palatoplasty in Comparison to Modified Furlow Palatoplasty Alone (SPEAC)
A Comparison of Speech Outcome in Pediatric Cleft Patients, After Modified Furlow Palatoplasty in Combination With Intravelar Veloplasty According to Sommerlad, or Modified Furlow Palatoplasty Alone
Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique.
study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator.
The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone.
conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department.
Study Overview
Status
Conditions
Detailed Description
Nowadays, surgical success of cleft palate patients is ascribed to the sufficiency of velopharyngeal closure, and the associated speech results such as voice nasality, resonance and articulation. The investigators aim to evaluate if the surgical modified Furlow palatoplasty in combination with the intravelar veloplasty according to Sommerlad significantly reduces the number of pediatric patients with abnormal speech between five and seven years of age, as measured with the four-point scale recently published by Nguyen et al.(2015), in comparison to the conventional modified Furlow technique.
study design A prospective cohort trial. All cleft palate patients surgically treated with a modified Furlow technique since January 2012 or a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad routinely undergo an annual speech evaluation by the speech language pathologist of the cleft team. At the age of five, eligible patients that are in continuous follow-up by the cleft team at our hospital, will be asked for consent to register their demographic, surgical and speech-related data. In addition, the parents of cleft patients will be asked to complete a quality of life questionnaire concerning their child, at the time of speech evaluation through self-report or through an interview with the clinical research coordinator.
The investigators hypothesise that the combined modified Furlow and Sommerlad palatoplasty leads to a minimal 50% reduction in the proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015), compared to patients that underwent a Modified Furlow technique alone.
conclusion Although the technique by Sommerlad has shown promising results, prospective trials comparing postoperative speech outcome after different surgical techniques, are lacking. The present trial could offer objective results to validate the current surgical treatment protocol implemented at our department.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Araceli Diez-Fraile
- Phone Number: +32 5045 9660
- Email: araceli.diez-fraile@azsintjan.be
Study Locations
-
-
-
Brugge, Belgium
- Recruiting
- Division of Oral and Maxillofacial Surgery, Department of Surgery, AZ Sint-Jan Brugge-Oostende AV
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients should have a clinically diagnosed cleft of the hard and/or soft palatum, with or without involvement of the lip or nose (Veau classification I to IV (see Appendix 1).
- Patients should have undergone a modified Furlow palatoplasty or modified Furlow according to Sommerlad in the AZ Sint-Jan Brugge-Oostende av
- Patients should receive their postoperative care and speech therapy by the cleft team of the general hospital Sint-Jan Bruges
- Patients should be in the fifth life year at time of speech evaluation
- Patients should be Dutch-speaking as a maternal language
Exclusion Criteria:
- Patients not meeting the abovementioned inclusion criteria
- Patients that received a corrective surgical procedure for velopharyngeal dysfunction after the modified Furlow technique alone, or in combination with the intravelar veloplasty by Sommerlad
- Patients that are bi- or multilingual
- Patients with clinically diagnosed mild hearing difficulties (i.e. ASHA classification: hearing loss >25dB)30
- Patients with a clinically diagnosed stutter
- Patients with clinically diagnosed cognitive and/or motoric disabilities
- Patients that received intensive speech therapy prior to their fifth life year can be included, but will be analyzed separately(subgroup analysis)
- Note: The number of patients with a uni- or bilateral cleft involving the lip or nose should be comparable between both groups, since this can interfere with speech and could bias comparison of speech outcome between different cleft subgroups.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
---|
Furlow group
All cleft palate patients surgically treated with a modified Furlow technique since January 2012
|
Furlow + Sommerlad group
All cleft palate patients surgically treated with a modified Furlow technique in combination with an intravelar veloplasty by Sommerlad
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015)
Time Frame: at time of routine speech evaluation between age 5-7 years old
|
proportion of children with abnormal speech, as defined by the four-point scale recently published by Nguyen et al.(2015)
|
at time of routine speech evaluation between age 5-7 years old
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
prevalence of speech problems, as defined by the perceptual evaluation
Time Frame: at time of routine speech evaluation between age 5-7 years old
|
prevalence of speech problems, as defined by the perceptual evaluation
|
at time of routine speech evaluation between age 5-7 years old
|
prevalence of speech problems, as defined by the objective speech evaluation (nasometry)
Time Frame: at time of routine speech evaluation between age 5-7 years old
|
prevalence of speech problems, as defined by the objective speech evaluation (nasometry)
|
at time of routine speech evaluation between age 5-7 years old
|
incidence of 30-day postoperative complications
Time Frame: within 30 days postoperative
|
incidence of 30-day postoperative complications
|
within 30 days postoperative
|
PVRQOL questionnaire, as a measure of quality of life
Time Frame: at time of routine speech evaluation between age 5-7 years old
|
PVRQOL questionnaire, as a measure of quality of life
|
at time of routine speech evaluation between age 5-7 years old
|
COHIP questionnaire, as a measure of quality of life
Time Frame: at time of routine speech evaluation between age 5-7 years old
|
COHIP questionnaire, as a measure of quality of life
|
at time of routine speech evaluation between age 5-7 years old
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- B049201629483
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cleft Palate Children
-
UMC UtrechtRadboud University Medical Center; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruitingCleft Lip and Palate | Cleft Palate Children | Cleft Alveolar RidgeNetherlands
-
AZ Sint-Jan AVCompletedCleft Palate ChildrenBelgium
-
Ann & Robert H Lurie Children's Hospital of ChicagoEnrolling by invitation
-
University GhentResearch Foundation FlandersRecruitingCleft Lip and Palate | Cleft Palate Children | Speech Therapy | Speech Disorders in ChildrenBelgium
-
Cairo UniversityUnknownCleft Palate Children | Laser
-
University Hospital, GhentUniversity GhentRecruiting
-
Assiut UniversityUnknownCleft Palate Children | BlockEgypt
-
Lagos State UniversityUniversity of Lagos, NigeriaRecruitingCleft Palate | Cleft Lip and Cleft Palate | Cleft Lip, Cleft Alveolus and Cleft PalateNigeria
-
Cairo UniversityRecruitingCleft Lip and Palate | Bilateral Cleft Lip/PalateEgypt
-
Umeå UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsRecruitingVelopharyngeal Insufficiency in Children With Isolated or Combined Cleft PalateSweden